Log in to save to my catalogue

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8284840

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

About this item

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

A neurotropic herpes simplex virus that was genetically inactivated to prevent replication in normal cells was injected into the brain tumors of 12 patients with tumors that had progressed during previous treatment. Eleven patients had some radiographic or clinical responses, with inflammation detected in some PET scans. The median survival was 12....

Alternative Titles

Full title

Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8284840

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8284840

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2024947

How to access this item